Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

Summary This international retrospective study of 593 Splenic Marginal Zone Lymphoma (SMZL) patients aimed to identify factors that determine treatment initiation and influence lymphoma‐specific survival (LSS). Logistic regression was used to identify the factors associated with treatment. A Cox reg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2012-10, Vol.159 (2), p.164-171
Hauptverfasser:	Montalbán, Carlos, Abraira, Víctor, Arcaini, Luca, Domingo-Domenech, Eva, Guisado-Vasco, Pablo, Iannito, Emilio, Mollejo, Manuela, Matutes, Estella, Ferreri, Andrés, Salar, Antonio, Rattotti, Sara, Carpaneto, Andrea, Pérez Fernández, Ricardo, Bello, José L., Hernández, Miguel, Caballero, Dolores, Carbonell, Felix, Piris, Miguel A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences clinical studies Disease-Free Survival Female Hematologic and hematopoietic diseases Hemoglobins - metabolism Humans L-Lactate Dehydrogenase - blood Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis lymphoid malignancies lymphoma Lymphoma, B-Cell, Marginal Zone - blood Lymphoma, B-Cell, Marginal Zone - mortality Lymphoma, B-Cell, Marginal Zone - therapy lymphoproliferative disease Male Medical sciences Middle Aged non-hodgkin lymphoma Platelet Count Retrospective Studies Risk Factors Splenic Neoplasms - blood Splenic Neoplasms - mortality Splenic Neoplasms - therapy Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!